Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Cells|February 15, 2022
The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer's DiseaseMicha M M Wilhelmus, Elisa Tonoli, Clare Coveney, et al.
The American Journal of Pathology|September 13, 2011
Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease PathogenesisMicha M M Wilhelmus, John G J M Bol, Elise S Van Haastert, et al.
Scientific Reports|January 28, 2017
Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelinationNathaly Espitia Pinzon, Berta Sanz-Morello, John J P Brevé, et al.
Amino Acids|November 10, 2016
Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1gfp/gfp miceNavina L Chrobok, Alexandre Jaouen, Keith K Fenrich, et al.
Ultrasound in Medicine & Biology|September 22, 2009
Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cellsLynda J M Juffermans, Annemieke van Dijk, Cees A M Jongenelen, et al.
Brain Pathology (Zurich, Switzerland)|August 25, 2010
Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?Miriam E van Strien, Benjamin Drukarch, John G Bol, et al.
Brain Pathology (Zurich, Switzerland)|August 5, 2008
Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brainMicha M M Wilhelmus, Sentini C S Grunberg, John G J M Bol, et al.
Frontiers in Cellular Neuroscience|July 18, 2019
Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor CellsNathaly Espitia Pinzon, Hanneke van Mierlo, Jenny C de Jonge, et al.
Neuropathology and Applied Neurobiology|February 10, 2022
Absence of tissue transglutaminase reduces amyloid-beta pathology in APP23 miceMicha M M Wilhelmus, Osoul Chouchane, Maarten Loos, et al.
Plos One|April 25, 2018
Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosisNavina L Chrobok, John G J M Bol, Cornelis A Jongenelen, et al.
Pageof 8